News|Articles|February 19, 2025
Executive Summary: Accelerating High-Titer Expression for Complex Next-Gen Biologics
Author(s)Catalent
The right cell line development technology can address production challenges associated with expression and scalability of complex biologics.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
2
Navigating the Next Wave of Biopharma Manufacturing Innovation
3
How Mitigation and Maintenance Protect Against Future Risk
4
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
5
